113 related articles for article (PubMed ID: 35679052)
21. Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs.
Brooks HL; O'Brien DC; Salvalaggio G; Dong K; Hyshka E
Drug Alcohol Rev; 2019 May; 38(4):423-427. PubMed ID: 31021491
[TBL] [Abstract][Full Text] [Related]
22. Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
O'Keefe D; Wilkinson A; Aitken C; Dietze P
PLoS One; 2018; 13(12):e0209280. PubMed ID: 30550588
[TBL] [Abstract][Full Text] [Related]
23. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
[TBL] [Abstract][Full Text] [Related]
24. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
25. Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.
Allen ST; White RH; O'Rourke A; Schneider KE; Weir BW; Lucas GM; Kilkenny ME; Sherman SG
AIDS Behav; 2021 Oct; 25(10):3377-3385. PubMed ID: 33886011
[TBL] [Abstract][Full Text] [Related]
26. Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities.
Zlotorzynska M; Weidle PJ; Paz-Bailey G; Broz D;
Int J Drug Policy; 2018 Dec; 62():51-58. PubMed ID: 30359873
[TBL] [Abstract][Full Text] [Related]
27. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.
Aspinall EJ; Nambiar D; Goldberg DJ; Hickman M; Weir A; Van Velzen E; Palmateer N; Doyle JS; Hellard ME; Hutchinson SJ
Int J Epidemiol; 2014 Feb; 43(1):235-48. PubMed ID: 24374889
[TBL] [Abstract][Full Text] [Related]
28. Correlates of sharing of needles and syringes among people who inject drugs in Dhaka city, Bangladesh.
Hemel MM; Reza MM; Shafiq TK; Kabir MI; Rana AM; Khan SI
J Infect Dev Ctries; 2021 Oct; 15(10):1497-1506. PubMed ID: 34780373
[TBL] [Abstract][Full Text] [Related]
29. Needle and syringe distribution trends in Western Australia, 1990 to 2009.
Lilley G; Mak DB; Fredericks T
Drug Alcohol Rev; 2013 May; 32(3):320-7. PubMed ID: 22963615
[TBL] [Abstract][Full Text] [Related]
30. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
[TBL] [Abstract][Full Text] [Related]
32. Trends in methamphetamine and opioid use among clients of needle-syringe programs in Queensland, Australia: 2007-2015.
Jacka B; Kemp R; Degenhardt L; Peacock A; Clare P; Bruno R; Dev A; Sotade O; Larance B
Drug Alcohol Rev; 2019 Feb; 38(2):159-168. PubMed ID: 30761653
[TBL] [Abstract][Full Text] [Related]
33. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
Deryabina A; El-Sadr WM
Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
[TBL] [Abstract][Full Text] [Related]
34. Accessibility of Needle and Syringe Programs and Injecting and Sharing Risk Behaviors in High Hepatitis C Virus Prevalence Settings.
Naserirad M; Beulaygue IC
Subst Use Misuse; 2020; 55(6):900-908. PubMed ID: 31918611
[No Abstract] [Full Text] [Related]
35. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
36. Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.
Hancock E; Ward Z; Ayres R; Neale J; Hussey D; Kesten JM; Hickman M; Vickerman P
Addiction; 2020 Apr; 115(4):702-713. PubMed ID: 31633849
[TBL] [Abstract][Full Text] [Related]
37. Individual-level syringe coverage among Needle and Syringe Program attendees in Australia.
Iversen J; Topp L; Wand H; Maher L
Drug Alcohol Depend; 2012 May; 122(3):195-200. PubMed ID: 22071120
[TBL] [Abstract][Full Text] [Related]
38. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
[TBL] [Abstract][Full Text] [Related]
39. Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.
Syvertsen JL; Pollini RA
Int J Drug Policy; 2020 Jan; 75():102594. PubMed ID: 31775079
[TBL] [Abstract][Full Text] [Related]
40. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
